CREB3L4

gene
On this page

Also known as AIbZIPCREB4CREB3hJALATCE1

Summary

CREB3L4 (cAMP responsive element binding protein 3 like 4, HGNC:18854) is a protein-coding gene on chromosome 1q21.3, encoding Cyclic AMP-responsive element-binding protein 3-like protein 4 (Q8TEY5). Transcriptional activator that may play a role in the unfolded protein response.

This gene encodes a CREB (cAMP responsive element binding) protein with a transmembrane domain which localizes it to the ER membrane. The encoded protein is a transcriptional activator which contains a dimerization domain, and this protein may function in a number of processing pathways including protein processing. Multiple transcript variants encoding different isoforms have been found for this gene.

Source: NCBI Gene 148327 — RefSeq curated summary.

At a glance

  • GWAS associations: 18
  • Clinical variants (ClinVar): 74 total — 2 pathogenic
  • MANE Select transcript: NM_001255978

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:18854
Approved symbolCREB3L4
NamecAMP responsive element binding protein 3 like 4
Location1q21.3
Locus typegene with protein product
StatusApproved
AliasesAIbZIP, CREB4, CREB3, hJAL, ATCE1
Ensembl geneENSG00000143578
Ensembl biotypeprotein_coding
OMIM607138
Entrez148327

Gene structure

Transcript identifiers

Ensembl transcripts: 46 — 40 protein_coding, 6 protein_coding_CDS_not_defined

ENST00000271889, ENST00000368600, ENST00000368601, ENST00000368603, ENST00000368607, ENST00000431292, ENST00000449724, ENST00000461688, ENST00000468845, ENST00000473340, ENST00000477617, ENST00000479010, ENST00000492729, ENST00000885128, ENST00000885129, ENST00000885130, ENST00000885131, ENST00000885132, ENST00000885133, ENST00000885134, ENST00000885135, ENST00000885136, ENST00000885137, ENST00000885138, ENST00000885139, ENST00000885140, ENST00000885141, ENST00000885142, ENST00000930318, ENST00000930319, ENST00000930320, ENST00000930321, ENST00000930322, ENST00000930323, ENST00000930324, ENST00000930325, ENST00000930326, ENST00000930327, ENST00000946154, ENST00000946155, ENST00000946156, ENST00000946157, ENST00000946158, ENST00000946159, ENST00000946160, ENST00000946161

RefSeq mRNA: 5 — MANE Select: NM_001255978 NM_001255978, NM_001255979, NM_001255980, NM_001255981, NM_130898

CCDS: CCDS1056, CCDS58029

Canonical transcript exons

ENST00000368607 — 10 exons

ExonStartEnd
ENSE00000960970153972972153973078
ENSE00001421042153967902153968164
ENSE00001865408153973872153974359
ENSE00003465238153972744153972836
ENSE00003503193153968930153969176
ENSE00003510416153973195153973263
ENSE00003525228153969334153969455
ENSE00003542152153968522153968699
ENSE00003617392153973620153973716
ENSE00003623170153973380153973464

Expression profiles

Bgee: expression breadth ubiquitous, 217 present calls, max score 95.81.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 8.5866 / max 121.2029, expressed in 1670 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
54575.86021534
54562.29521054
54580.3595156
54590.071839

Top tissues by expression

256 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
parotid glandUBERON:000183195.81gold quality
right uterine tubeUBERON:000130295.00gold quality
prostate glandUBERON:000236794.41gold quality
saliva-secreting glandUBERON:000104492.40gold quality
minor salivary glandUBERON:000183091.76gold quality
body of stomachUBERON:000116189.35gold quality
left ovaryUBERON:000211989.12gold quality
right lobe of liverUBERON:000111488.73gold quality
olfactory segment of nasal mucosaUBERON:000538688.63gold quality
mouth mucosaUBERON:000372988.51gold quality
pancreatic ductal cellCL:000207988.23gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099188.22gold quality
right ovaryUBERON:000211888.05gold quality
stomachUBERON:000094587.98gold quality
mucosa of transverse colonUBERON:000499187.57gold quality
body of pancreasUBERON:000115087.45gold quality
rectumUBERON:000105287.35gold quality
oviduct epitheliumUBERON:000480487.02gold quality
endocervixUBERON:000045886.90gold quality
ovaryUBERON:000099286.65gold quality
fallopian tubeUBERON:000388986.34gold quality
right lobe of thyroid glandUBERON:000111986.10gold quality
ileal mucosaUBERON:000033186.01gold quality
right adrenal glandUBERON:000123385.60gold quality
epithelium of mammary glandUBERON:000324485.51gold quality
mammary ductUBERON:000176585.42gold quality
fundus of stomachUBERON:000116085.30gold quality
ganglionic eminenceUBERON:000402385.14gold quality
right adrenal gland cortexUBERON:003582784.99gold quality
left lobe of thyroid glandUBERON:000112084.96gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-75688yes424.90
E-ANND-3yes3.72
E-CURD-10no109.16

Regulation

Is transcription factor: yes

Downstream targets (CollecTRI)

3 targets.

TargetRegulation
CREB3L4
DNAJC12Unknown
HSPA5Activation

JASPAR motifs

MotifNameFamily
MA1474.1CREB3L4CREB-related factors
MA1474.2CREB3L4CREB-related factors
MA1475.1CREB3L4CREB-related factors
MA1475.2CREB3L4CREB-related factors

JASPAR matrix evidence (PMIDs): PMID:21711675

Upstream regulators (CollecTRI, top): CREB3L4, CREM

miRNA regulators (miRDB)

11 targeting CREB3L4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4692100.0067.322066
HSA-MIR-451499.9967.101870
HSA-MIR-132399.8369.892471
HSA-MIR-548O-3P99.7469.302228
HSA-MIR-6892-3P99.6866.401178
HSA-MIR-186-3P99.5166.241685
HSA-MIR-4640-5P97.4266.331543
HSA-MIR-4726-5P97.2465.671299
HSA-MIR-424-3P97.2065.86385
HSA-MIR-6747-5P96.1764.99743
HSA-MIR-4772-5P95.6068.04617

Literature-anchored findings (GeneRIF, showing 10)

  • AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells. (PMID:11830526)
  • identified a novel human CREB gene (CREB4) that was 1592 bp long and encoded a protein of 395 amino acid residues (PMID:12111373)
  • S1P cleavage of CREB4 may be suppressed by a determinant in the C-terminal region (PMID:16236796)
  • In LNCaP cell lines that conditionally express the processed form of AIbZIP, downstream targets of AIbZIP include genes for protein processing, transcriptional regulation, small molecule transport, signal transduction, metabolism & cell homeostasis. (PMID:17712038)
  • AIbZIP induced by the androgen receptor axis plays a crucial role in the p21 dependent proliferation of androgen-sensitive prostate cancer cells. (PMID:27853318)
  • CREB3L4 expression is mediated by an androgen-receptor -IRE1alpha axis, but is also directly regulated by androgen-receptor-to-androgen response elements binding. (PMID:28338058)
  • Study demonstrated that MCU1 is frequently overexpressed in breast cancer and abnormally high expression of MUC1 indicates poor prognosis. Subsequent data mining across multiple large databases demonstrated a positive association between MUC1 mRNA expression CREB3L4 in breast cancer tissues. Results indicated that MUC1 transcript expression may regulate tumor invasion and metastasis associated with CREB3L4 transcription. (PMID:30483806)
  • The Novel Transcription Factor CREB3L4 Contributes to the Progression of Human Breast Carcinoma. (PMID:32026099)
  • MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway. (PMID:33106913)
  • AIbZIP/CREB3L4 Promotes Cell Proliferation via the SKP2-p27 Axis in Luminal Androgen Receptor Subtype Triple-Negative Breast Cancer. (PMID:38236913)

Cross-species orthologs

8 orthologs

OrganismSymbolGene ID
mus_musculusCreb3l4ENSMUSG00000027938
rattus_norvegicusCreb3l4ENSRNOG00000023493
drosophila_melanogasterCrebAFBGN0004396
drosophila_melanogasterAtf6FBGN0033010
drosophila_melanogasterCrebBFBGN0265784
caenorhabditis_elegansWBGENE00000222
caenorhabditis_elegansWBGENE00000793
caenorhabditis_elegansWBGENE00016162

Paralogs (9): CREB3L3 (ENSG00000060566), CREM (ENSG00000095794), CREB3 (ENSG00000107175), ATF6 (ENSG00000118217), CREB1 (ENSG00000118260), ATF1 (ENSG00000123268), CREB3L1 (ENSG00000157613), CREB3L2 (ENSG00000182158), ATF6B (ENSG00000213676)

Protein

Protein identifiers

Cyclic AMP-responsive element-binding protein 3-like protein 4Q8TEY5 (reviewed: Q8TEY5)

Alternative names: Androgen-induced basic leucine zipper protein, Attaching to CRE-like 1, Cyclic AMP-responsive element-binding protein 4, Transcript induced in spermiogenesis protein 40, hJAL

All UniProt accessions (4): Q8TEY5, Q5T4K9, Q5T4L1, Q5T4L2

UniProt curated annotations — full annotation on UniProt →

Function. Transcriptional activator that may play a role in the unfolded protein response. Binds to the UPR element (UPRE) but not to CRE element. Preferentially binds DNA with to the consensus sequence 5’-T[GT]ACGT[GA][GT]-3’ and has transcriptional activation activity from UPRE. Binds to NF-kappa-B site and has transcriptional activation activity from NF-kappa-B-containing regulatory elements.

Subunit / interactions. Binds DNA as a dimer.

Subcellular location. Endoplasmic reticulum membrane. Golgi apparatus membrane Nucleus.

Tissue specificity. According to PubMed:11830526, exclusively expressed in the prostate. Expressed in breast and prostate cancer cell lines. Expressed in prostatic luminal epithelial cells (at protein level). Expression is significantly more abundant in prostate cancer than in benign prostatic tissue (prostatic hyperplasia). According to PubMed:12111373, also expressed in brain, pancreas and skeletal muscle, and at lower levels in small intestine, testis, leukocyte and thymus.

Post-translational modifications. N-glycosylated in the C-terminal region. Controlled by regulated intramembrane proteolysis (RIP). Following ER stress a fragment containing the cytoplasmic transcription factor domain is released by proteolysis. The cleavage seems to be performed sequentially by site-1 and site-2 proteases (PS1 and PS2). PS1 cleavage may be suppressed by a determinant in the C-terminal region.

Induction. By androgens.

Similarity. Belongs to the bZIP family. ATF subfamily.

Isoforms (2)

UniProt IDNamesCanonical?
Q8TEY5-11yes
Q8TEY5-22

RefSeq proteins (5): NP_001242907, NP_001242908, NP_001242909, NP_001242910, NP_570968 (=MANE)

Domains & families (InterPro)

IDNameType
IPR004827bZIPDomain
IPR046347bZIP_sfHomologous_superfamily
IPR051381CREB_ATF_subfamilyFamily

Pfam: PF00170

UniProt features (16 total): region of interest 4, chain 2, topological domain 2, site 1, glycosylation site 1, splice variant 1, sequence variant 1, mutagenesis site 1, sequence conflict 1, transmembrane region 1, domain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8TEY5-F161.560.22

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (1): 338–339 (cleavage; by ps1)

Glycosylation sites (1): 366

Mutagenesis-validated functional residues (1):

PositionPhenotype
335abolishes cleavage by sp1.

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-8874211CREB3 factors activate genes

MSigDB gene sets: 353 (showing top): GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS, GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT, REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR, GOBP_MYELOID_LEUKOCYTE_MIGRATION, GOBP_CELL_CHEMOTAXIS, GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS, STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN, GOBP_GROWTH, GOBP_INDUCTION_OF_POSITIVE_CHEMOTAXIS, TGACCTY_ERR1_Q2, AP2_Q3, GOBP_MALE_GAMETE_GENERATION, GGGTGGRR_PAX4_03, GOBP_REGULATION_OF_POSITIVE_CHEMOTAXIS, GOBP_REGULATION_OF_LEUKOCYTE_MIGRATION

GO Biological Process (5): regulation of transcription by RNA polymerase II (GO:0006357), response to unfolded protein (GO:0006986), spermatogenesis (GO:0007283), positive regulation of transcription by RNA polymerase II (GO:0045944), regulation of DNA-templated transcription (GO:0006355)

GO Molecular Function (8): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228), sequence-specific double-stranded DNA binding (GO:1990837), RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), protein binding (GO:0005515)

GO Cellular Component (10): Golgi membrane (GO:0000139), chromatin (GO:0000785), nucleus (GO:0005634), nucleoplasm (GO:0005654), mitochondrion (GO:0005739), endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), Golgi apparatus (GO:0005794), nuclear membrane (GO:0031965), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Unfolded Protein Response (UPR)1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
intracellular membrane-bounded organelle4
RNA polymerase II transcription regulatory region sequence-specific DNA binding3
cellular anatomical structure3
cytoplasm3
regulation of DNA-templated transcription2
transcription by RNA polymerase II2
regulation of transcription by RNA polymerase II2
transcription cis-regulatory region binding2
endomembrane system2
organelle membrane2
response to topologically incorrect protein1
developmental process involved in reproduction1
male gamete generation1
positive regulation of DNA-templated transcription1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
cis-regulatory region sequence-specific DNA binding1
chromatin1
DNA-binding transcription factor activity1
DNA-binding transcription factor activity, RNA polymerase II-specific1
DNA-binding transcription activator activity1
positive regulation of transcription by RNA polymerase II1
double-stranded DNA binding1
sequence-specific DNA binding1
nucleic acid binding1
transcription regulator activity1
binding1
Golgi apparatus1
bounding membrane of organelle1
chromosome1
nuclear lumen1
nuclear outer membrane-endoplasmic reticulum membrane network1
endoplasmic reticulum subcompartment1
nucleus1
nuclear envelope1

Protein interactions and networks

STRING

806 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CREB3L4HCFC1P51610882
CREB3L4HCFC2Q9Y5Z7832
CREB3L4CREBZFQ9NS37790
CREB3L4HDAC3O15379788
CREB3L4CREBRFQ8IUR6752
CREB3L4MBTPS1Q14703571
CREB3L4MBTPS2O43462566
CREB3L4CREB1P16220548
CREB3L4FBXL20Q96IG2543
CREB3L4FBXL2Q9UKC9541
CREB3L4PAQR4Q8N4S7530
CREB3L4ARF4P18085510
CREB3L4EIF2AK2P19525496
CREB3L4EIF2S3P41091494
CREB3L4XBP1P17861478

IntAct

12 interactions, top by confidence:

ABTypeScore
GET3CREB3L4psi-mi:“MI:0915”(physical association)0.560
CREB3MYO9Apsi-mi:“MI:0914”(association)0.530
CREB3L4CREB3psi-mi:“MI:2364”(proximity)0.480
GANABCREB3L4psi-mi:“MI:0915”(physical association)0.370
CREB3L4LRRC4Cpsi-mi:“MI:0915”(physical association)0.370
SLC19A3CREB3L4psi-mi:“MI:0915”(physical association)0.370
ESR1ESYT2psi-mi:“MI:0914”(association)0.350
CREB3L3AP3B1psi-mi:“MI:0914”(association)0.350
GET3CREB3L4psi-mi:“MI:0915”(physical association)0.000

BioGRID (14): CREB3L4 (Affinity Capture-RNA), CREB3L4 (Affinity Capture-RNA), CREB3L4 (Co-localization), CREB3L4 (Affinity Capture-MS), ASNA1 (Two-hybrid), CREB3L4 (Affinity Capture-MS), CREB3L4 (Affinity Capture-MS), CREB3L4 (Affinity Capture-MS), CREB3L4 (Affinity Capture-MS), CREM (Affinity Capture-Western), CREB3L4 (Reconstituted Complex), LRRC4C (Two-hybrid), GANAB (Two-hybrid), SLC19A3 (Two-hybrid)

ESM2 similar proteins: A1L224, A2VD01, D3ZLB7, F6VAN0, G3V909, O02761, O35451, O43889, O77628, O88479, O94983, O97930, P01100, P01101, P01102, P0C0N8, P0C0N9, P11939, P12841, P18850, P20389, P38532, Q00613, Q08CW8, Q08DJ8, Q1LYG4, Q3SYZ3, Q502F0, Q56TN0, Q56TT7, Q5FVM5, Q5RCM9, Q5UEM7, Q5UEM8, Q61817, Q64210, Q66HA2, Q68CJ9, Q6QDP7, Q6ZPJ0

Diamond homologs: A1L224, A2VD01, O43889, O44743, P29747, Q08CW8, Q1LYG4, Q3SYZ3, Q4JFH9, Q502F0, Q5FVM5, Q5RCM9, Q5UEM7, Q5UEM8, Q61817, Q66HA2, Q68CJ9, Q6QDP7, Q70SY1, Q8BH52, Q8SQ19, Q8TEY5, Q91XE9, Q96BA8, Q9D2A5, Q9Z125, F6VAN0, G3V909, O35451, P18850, Q99941, Q54Y73, P27699, Q03060, Q03061, Q1LZH5, Q54RZ9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

74 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic2
Likely pathogenic0
Uncertain significance49
Likely benign6
Benign0

Top pathogenic / likely-pathogenic (2)

Variant IDHGVSClassification
2426580NC_000001.10:g.(?153782653)(153964569_?)delPathogenic
60012GRCh38/hg38 1q21.3(chr1:153939571-153978276)x1Pathogenic

SpliceAI

3590 predictions. Top by Δscore:

VariantEffectΔscore
1:153972736:A:AGacceptor_gain1.0000
1:153972737:C:Gacceptor_gain1.0000
1:153972742:A:AGacceptor_gain1.0000
1:153972743:G:GAacceptor_gain1.0000
1:153972743:GCT:Gacceptor_gain1.0000
1:153973193:AG:Aacceptor_gain1.0000
1:153973194:GG:Gacceptor_gain1.0000
1:153973260:ACAT:Adonor_gain1.0000
1:153973261:CAT:Cdonor_gain1.0000
1:153973262:AT:Adonor_gain1.0000
1:153973263:TGTG:Tdonor_loss1.0000
1:153973264:G:GAdonor_loss1.0000
1:153973264:G:GGdonor_gain1.0000
1:153973265:T:Adonor_loss1.0000
1:153973266:G:GTdonor_loss1.0000
1:153973714:G:GTdonor_gain1.0000
1:153973870:A:AGacceptor_gain1.0000
1:153973871:G:GAacceptor_gain1.0000
9:35732902:GTAG:Gdonor_loss1.0000
9:35733214:GAGA:Gacceptor_gain1.0000
9:35735096:T:Aacceptor_gain1.0000
9:35735107:A:AGacceptor_gain1.0000
9:35735108:G:GCacceptor_gain1.0000
9:35735108:GA:Gacceptor_gain1.0000
9:35735108:GAC:Gacceptor_gain1.0000
9:35735108:GACA:Gacceptor_gain1.0000
9:35735180:G:GTdonor_gain1.0000
9:35735181:A:Tdonor_gain1.0000
9:35735186:G:GTdonor_gain1.0000
9:35735187:A:Tdonor_gain1.0000

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000001382 (1:153972654 A>G), RS1000069787 (1:153967407 G>C), RS1000101967 (1:153967761 G>A), RS1001142587 (1:153966841 T>C), RS1001172019 (1:153967289 C>G), RS1001193282 (1:153967887 C>G,T), RS1002434171 (1:153974501 A>C,G), RS1002811548 (1:153974044 G>A), RS1002848754 (1:153965533 A>C), RS1003656024 (1:153970838 A>G), RS1003788759 (1:153971056 C>G), RS1004144381 (1:153970397 G>A,T), RS1004520784 (1:153970143 G>A), RS1005358731 (1:153967359 C>G,T), RS1005433438 (1:153968909 T>A,C)

Disease associations

OMIM: gene MIM:607138 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

18 associations (top):

StudyTraitp-value
GCST003795_1Age at first birth6.000000e-10
GCST004865_47Itch intensity from mosquito bite adjusted by bite size9.000000e-06
GCST005751_3Empathy quotient3.000000e-07
GCST006044_1Age at first birth3.000000e-07
GCST006045_3Age at first birth5.000000e-06
GCST006585_2820Blood protein levels2.000000e-30
GCST010136_18Fruit consumption3.000000e-08
GCST010137_3Cooked vegetable consumption3.000000e-09
GCST010142_60Fish- and plant-related diet4.000000e-09
GCST010142_92Fish- and plant-related diet6.000000e-14
GCST010696_22Cortical thickness (min-P)4.000000e-10
GCST010697_50Cortical surface area (min-P)1.000000e-12
GCST010698_81Subcortical volume (min-P)1.000000e-23
GCST010699_7Brain morphology (min-P)1.000000e-10
GCST010700_11Cortical thickness (MOSTest)4.000000e-13
GCST010701_73Cortical surface area (MOSTest)4.000000e-09
GCST010702_45Subcortical volume (MOSTest)4.000000e-10
GCST010703_276Brain morphology (MOSTest)2.000000e-15

EFO canonical traits (7, from GWAS)

EFO IDTrait name
EFO:0009101age at first birth measurement
EFO:0008377mosquito bite reaction itch intensity measurement
EFO:0008378mosquito bite reaction size measurement
EFO:0009183empathy measurement
EFO:0008111diet measurement
EFO:0004346neuroimaging measurement
EFO:0004840cortical thickness

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

35 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects expression, decreases expression6
Carbamazepineaffects expression2
Estradioldecreases expression2
Nickeldecreases expression2
Phenylmercuric Acetateaffects cotreatment, decreases expression2
GSK-J4decreases expression1
methylmercuric chloridedecreases expression1
methylselenic acidaffects expression1
sodium arsenitedecreases expression1
ferrous chloridedecreases expression1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic acidincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amidedecreases expression1
dorsomorphinaffects cotreatment, decreases expression1
jinfukangincreases expression1
Resveratrolaffects cotreatment, decreases expression1
Sunitinibdecreases expression1
Atrazinedecreases expression1
Chelating Agentsaffects binding, affects expression1
Copperaffects binding, affects expression1
Coumestrolaffects cotreatment, decreases expression1
Diclofenacaffects expression1
Formaldehydeincreases expression1
Hydrogen Peroxideaffects expression1
Methyl Methanesulfonateincreases expression1
Dihydrotestosteroneincreases expression1
Tetrachlorodibenzodioxindecreases expression1
Tobacco Smoke Pollutiondecreases expression1
Tunicamycinincreases expression1

Cellosaurus cell lines

1 cell lines: 1 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_D8J8Ubigene HCT 116 CREB3L4 KOCancer cell lineMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.